Computational modelling of potential Zn-sensitive non-β-lactam inhibitors of imipenemase-1 (IMP-1)
Loading...
Date
Journal Title
Journal ISSN
Volume Title
Publisher
Taylor & Francis
DOI
Abstract
Antibiotic resistance (AR) remains one of the leading global health challenges, mostly implicated in
disease-related deaths. The Enterobacteriaceae-producing metallo-b-lactamases (MBLs) are critically
involved in AR pathogenesis through Zn-dependent catalytic destruction of b-lactam antibiotics, yet
with limited successful clinical inhibitors. The efficacy of relevant broad-spectrum b-lactams including
imipenem and meropenem are seriously challenged by their susceptibility to the Zn-dependent carbapenemase
hydrolysis, as such, searching for alternatives remains imperative. In this study, computational
molecular modelling and virtual screening methods were extensively applied to identify new
putative Zn-sensitive broad-spectrum inhibitors of MBLs, specifically imipenemase-1 (IMP-1) from the
IBScreen database. Three ligands, STOCK3S-30154, STOCK3S-30418 and STOCK3S-30514 selectively
displayed stronger binding interactions with the enzymes compared to reference inhibitors, imipenem
and meropenem. For instance, the ligands showed molecular docking scores of 9.450, 8.005 and
10.159 kcal/mol, and MM-GBSA values of 40.404, 31.902 and 33.680 kcal/mol respectively
against the IMP-1. Whereas, imipenem and meropenem showed docking scores of 9.038 and
10.875 kcal/mol, and MM-GBSA of 31.184 and 32.330 kcal/mol respectively against the enzyme.
The ligands demonstrated good thermodynamic stability and compactness in complexes with IMP-1
throughout the 100 ns molecular dynamics (MD) trajectories. Interestingly, their binding affinities and
stabilities were significantly affected in contacts with the remodelled Zn-deficient IMP-1, indicating
sensitivity to the carbapenemase active Zn site, however, with non-b-lactam scaffolds, tenable to resist
catalytic hydrolysis. They displayed ideal drug-like ADMET properties, thus, representing putative Znsensitive
non-b-lactam inhibitors of IMP-1 amenable for further experimental studies
Description
Keywords
Citation
Ayipo Y. O., Ahmad I., Alananzeh W. A., Lawal A., Patel H., Mordi M. N.: Computational modelling of potential Zn-sensitive non-β-lactam inhibitors of imipenemase-1 (IMP-1), Journal of Biomolecular Structure and Dynamics, 2022, 41(19), 1-22. https://doi.org/10.1080/07391102.2022.2153168
